Dr. Xiang Wang is a Senior Researcher associated with the California NanoSystems Institute at the University of California, Los Angeles. He earned a Ph.D. in Occupational and Environmental Health from Peking University. With two decades of experience, he has dedicated his career to research in nanotoxicology and nanomedicine. Dr. Wang is at the forefront of innovative endeavors in the development of mRNA lipid nanoparticle therapeutics, contributing significantly to advancements in diagnosis, therapy, and prophylactic applications. His expertise spans various domains, notably in cancer, allergies, autoimmune diseases, and beyond. Dr. Wang's primary focus lies in the creation of meticulously designed nano-platforms, ensuring their safety for biomedical and pharmaceutical applications. His extensive work encompasses a range of formulations, including polymeric and lipid-based nanostructures, etc.
Dr. Xiang Wang is a Senior Researcher associated with the California NanoSystems Institute at the University of California, Los Angeles. He earned a Ph.D. in Occupational and Environmental Health from Peking University. With two decades of experience, he has dedicated his career to research in nanotoxicology and nanomedicine. Dr. Wang is at the forefront of innovative endeavors in the development of mRNA lipid nanoparticle therapeutics, contributing significantly to advancements in diagnosis, therapy, and prophylactic applications. His expertise spans various domains, notably in cancer, allergies, autoimmune diseases, and beyond. Dr. Wang's primary focus lies in the creation of meticulously designed nano-platforms, ensuring their safety for biomedical and pharmaceutical applications. His extensive work encompasses a range of formulations, including polymeric and lipid-based nanostructures, etc.